Key challenges
Combinati's hardware instruments required a sophisticated software solution to enable efficient Data Processing and Analysis, ensuring researchers could work seamlessly with the dPCR, short for Digital PCR, a cutting-edge molecular biology technique used to quantify and amplify nucleic acid, such as DNA or RNA, results in a sample
The development of the software was aimed at democratizing Digital PCR, empowering researchers worldwide with accessible and impactful disease-driven biomarker tracking and healthcare information
Developing a cutting-edge dPCR platform that drastically reduced processing time by ~90 minutes while maintaining high levels of accuracy and precision in analysis
Client in spotlight
Combinati believes simplicity shouldn’t require sacrificing robustness, quality or rigor – in fact, it should enable it. The customer’s easy-to-use Digital PCR platform offers absolute quantification to track disease-relevant biomarkers over time with high accuracy and precision. Comprised of a single instrument and a single consumable, the core microfluidic technology enables the partitioning of samples with minimal waste. Combined with the ability to robustly reject false positives and easily adapt traditional qPCR assays, Combinati aimed to democratize Digital PCR for researchers all over the world.
Unlocking Digital Success
